Inhibition of the EGFR / STAT 3 / CEBPD axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder
暂无分享,去创建一个
C. Yen | Chien-Feng Li | T. Hour | Wen-Chang Chang | Yu-hui Wang | Ju-Ming Wang | Wei-Jan Wang | Yu‐Yi Chu | Wei‐Jan Wang